Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasburicase vs Allopurinol for Hyperuricemia in Hematological Malignancies
NCT00607152Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Oct 2007
- Primary completion
- Jan 2009
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of rasburicase in hyperuricemia, sponsored by Sanofi. Started Oct 2007; status: terminated.
02
Drugs
rasburicase
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT00607152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607152.